by University of Bristol Credit: Pixabay/CC0 Public Domain High doses of a widely-used drug used in the hormonal treatment of conditions such as excessive hair growth, early puberty, prostate cancer, are linked to an increased risk of meningioma—the most common type of benign brain tumor, finds a University of Bristol-led study of over 8-million patients. The...
